Antibiotic susceptibility pattern among Staphylococcus spp. with emphasis on detection of mecA gene in methicillin resistant Staphylococcus aureus isolates

Iranian Journal of Clinical Infectious Diseases

Volumn 4, Issue 3, 2009, Pages 143-150

  Rahimi, Fateh ^a   Bouzari, Majid ^a   Maleki, Zohreh ^b   Rahimi, Fermisk ^c  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

mecA; Methicillin; MRSA; Staphylococcus aureus

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; METICILLIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SAPROPHYTICUS;

EID: 77953401829     PISSN: 17355109     EISSN: 20081081     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hartman BJ, Tomasz A. Low-affinity penicillinbinding protein associated with β-lactam resistance in Staphylococcus aureus. J Bacteriol 1984;158:513-16.
2. Reynolds PE, Fuller C. Methicillin-resistant strains of Staphylococcus aureus; presence of identical additional penicillin-binding protein in all strains examined. FEMS Microbiol Lett 1986;33:251-54.
3. Wise EM, Park JT. Penicillin: its basic site of action as an inhibitor of a peptide crosslinking reaction in cell wall mucopeptide synthesis. Proc Natl Acad Sci. USA 1965;54:75-81.
4. Waks RG, Lewis K, Salyers AA. Bacterial resistance to antimicrobials. CRC Press, Taylor and Francis Group, 2008.
5. Srifuengfung S. Methicillin-resistant Staphylococcus aureus (MRSA): Review of problems and comments. J Infect Dis Antimicrob Agents 1994;11:141-7.
6. Bradley SF. Methicillin-resistant Staphylococcus aureus infection. Clin Geriatr Med 1992;8:843-68.
7. Bamberger DM, Boyd SE. Management of Staphylococcus aureus infections. Am Fam Phys 2005;72:2474-81.
8. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520-32.
9. Tenover FC, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 2001;7:327-32.
10. World Health Organization. WHO global strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001.2. Geneva: The Organization; 2001 [cited 21 Jan 2004].
11. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001;7:178-82.
12. Hiramatsu K. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am J Med 1998;104:7-10.
13. Barbar M. Methicillin-resistant staphylococci. J Clin Pathol 1961;14:385-93.
14. Bulger RJ. A methicillin-resistant strain of Staphylococcus aureus: clinical and laboratory experience. Annal Intern Med 1967;67:81-89.
15. Barrett FF, McGehee RF, Finland M. Methicillinresistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Eng J Med 1968;279:441-48.
16. Alborzi A, Pourabbas BA, Salehi H, et al. Prevalence and pattern of antibiotic sensitivity of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in shiraz. Iran J Med Sci 2000;25:1-8.
17. Japooni A, Alborzi A, Orafa F, Rasouli M, Farshad S. Distribution patterns of methicillin resistance genes (mecA) in Staphylococcus aureus isolated from clinical specimens. Iran Biomed J 2004;8:173-78.
18. MacFadin JF, editor. Biochemical tests for identification of medical bacteria. Lippincott: Willialms and Wilkins, 2000.
19. Winn WC, Allen SD, Janda WM, editors. Koneman's color atlas and textbook of diagnostic microbiology. Lippincott: Willialms and Wilkins, 2006.
20. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 11th informational supplement, vol. 21. National Committee for Clinical Laboratory Standards, Wayne, Pa, USA; 2001.
21. National Committee for Clinical Laboratory Standard. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A5. MIC testing. NCCLS.Villanova, Pa, USA; 2000.
22. Verhoef J. Stopping short the spread of methicillinresistant Staphylococcus aureus. CMAJ 2001;165:31-32.
23. Tanaka Y, Adachi A, Tanaka M. Epidemiological surveys of methicillin-resistant Staphylococcus aureus in Tottori Prefecture, Japan. Yonago Acta medica 1999;42:193-200.
24. Sax H, Harbarth S, Gavazzi G. Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital. Age Ageing 2005;34;456-62.
25. Vahdani P, Saifi, M, Aslani MM. Antibiotic resistant patterns in MRSA isolates from patients admitted in ICU and infectious ward. Tanaffos 2004;3:37-44.
26. Udo FF, Jacob IF, Mathew R. Genetic analysis of methicillin resistant Staphylococcus aureus expressing high and low level mupriocin resistance. J Med Microbiol 2001;50:909- 15.
27. Chambers HF. Methicillin resistance in staphylococci. Molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997;10:781-91.
28. Hiramatsu K. Molecular evolution of MRSA. Microbiol Immunol 1995;39:531-43.
29. Kobayashi N, Wu H, Kojima K, Taniguchi K, Urasawa S, Uehara N, et al. Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiol Infect 1994;113: 59-266.
30. Ryffel C, Tesch W, Birch-Machin I, Reynolds PE, Barberis-Maino L, Kayser FH, et al. Sequence comparison of mecA genes isolated from methicillinresistant Staphylococcus aureus and Staphylococcus epidermidis. Gene 1990;94:137-38.
31. Suzuki E, Hiramatsu K, Yokota T. Survey of methicillin-resistant clinical strains of coagulasenegative staphylococci for mecA gene distribution. Antimicrob Agents Chemother 1992;36 429-34.
32. Ubukata K, Nonoguchi R, Song MD, Matsuhashi M, Konno M. Homology of mecA gene in methicillinresistant Staphylococcus haemolyticus and Staphylococcus simulans to that of Staphylococcus aureus. Antimicrob Agents Chemother. 1990;34:170-72.
33. Chambers HF. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. J Infect Dis 1999;179:353-59.
34. Tomasz A, Drugeon HB, de Lencastre HM, Jabes D, McDougall L, Bille J. New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP2a gene and contain normal penicillin-binding proteins with modified penicillin binding capacity. Antimicrob Agents Chemother 1989;33(11):1869-74.